One of the global frontrunners in vaccination against the coronavirus, Spain on Wednesday it had fully vaccinated just over 70 percent of its 47 million residents. According to the latest figures released by the Spanish health ministry, some 33,376,693 people…
Read More‘Reservoir of disease’ within young population shows challenge for Washington’s reopening plans
An analysis of Washington state Department of Health data—published after peer review March 24—has found that people under 40 years old have continued to become infected by the coronavirus at increasing rates even as the incidence of infection among older…
Read MorePartnership with churches increases COVID-19 vaccine delivery among Black population
Incorporating Black churches and clergy in COVID-19 vaccination education and distribution has been found to be an effective model in helping to increase vaccination delivery to historically at-risk populations in San Bernardino County, a study says. Focused education efforts and…
Read MoreFrench nuclear tests infected ‘almost entire Polynesian population’: report
France concealed the levels of radioactivity that French Polynesia was exposed to during French nuclear tests in the Pacific from 1966-1996, with almost the “entire population” of the overseas territory infected, a report said on Tuesday. Online investigation site Disclose…
Read MoreMajor cardiovascular risk factor rates are high in the U.S. Hispanic/Latino population
The rate of cardiovascular risk factors among Hispanic/Latino people living in the U.S. is very high, and while they are often aware of their health conditions, less than half of the Hispanic/Latino adults with history of stroke or transient ischemic…
Read MoreSpain to vaccinate third of population by June: PM
Spain plans to vaccinate at least a third of its 47 million residents by June, Prime Minister Pedro Sanchez said on Friday, with the COVID-19 immunisation campaign to start in January. Some 2.5 million people will be vaccinated in the…
Read MoreA novel monoclonal antibody therapy cuts LDL cholesterol by half in a high-risk patient population
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol—the so-called “bad” cholesterol—by 50 percent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from the Icahn School of Medicine of Mount Sinai and…
Read MoreMore than half of the Dutch population expressed privacy concerns relating to the coronavirus app
According to research by University of Twente researchers, last summer, 68% of Dutch people were moderately to very concerned about possible privacy issues resulting from the type of information a coronavirus app collects. In addition to privacy-related concerns, many citizens…
Read MoreSymptoms of COVID-19 are a poor marker of infection, new UK population study shows
86% of UK residents who tested positive for COVID-19 during lockdown did not have the specific virus symptoms (cough, and/or fever, and/or loss of taste/smell), finds a new study by UCL researchers. The authors say a more widespread testing programme…
Read More